Bicycle Therapeutics Stock Performance
| BCYC Stock | USD 5.73 0.27 4.50% |
The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bicycle Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bicycle Therapeutics is expected to be smaller as well. At this point, Bicycle Therapeutics has a negative expected return of -0.0824%. Please make sure to confirm Bicycle Therapeutics' standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Bicycle Therapeutics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bicycle Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bicycle Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (7.55) | Five Day Return (8.81) | Year To Date Return (10.18) | Ten Year Return (50.00) | All Time Return (50.00) |
1 | Institutional Owners May Take Dramatic Actions as Bicycle Therapeutics Plcs Recent 25 percent Drop Adds to One-year Losses - | 11/06/2025 |
2 | Bicycle Therapeutics Initiated with a Hold at Truist Financial - The Globe and Mail | 11/25/2025 |
3 | Is Bicycle Therapeutics In A Good Position To Deliver On Growth Plans | 11/28/2025 |
4 | Is Bicycle Therapeutics plc stock in buy zone after pullback - 2025 Investor Takeaways Long-Term Growth Portfolio Plans - Newser | 12/02/2025 |
5 | Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline - Ya... | 12/15/2025 |
6 | Acquisition by Baker Bros. Advisors Lp of 38000 shares of Bicycle Therapeutics at 7.08 subject to Rule 16b-3 | 01/02/2026 |
7 | Disposition of 10989 shares by Lee Kevin of Bicycle Therapeutics at 6.46 subject to Rule 16b-3 | 01/05/2026 |
8 | Is Bicycle Therapeutics plc Depositary Receipt stock near bottom after decline - July 2025 Institutional Capital Efficient Trading Techniques - ulpravda.ru | 01/08/2026 |
9 | Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 | 01/12/2026 |
10 | Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline | 02/03/2026 |
| Begin Period Cash Flow | 527 M | |
| Total Cashflows From Investing Activities | -1.2 M |
Bicycle Therapeutics Relative Risk vs. Return Landscape
If you would invest 651.00 in Bicycle Therapeutics on November 6, 2025 and sell it today you would lose (51.00) from holding Bicycle Therapeutics or give up 7.83% of portfolio value over 90 days. Bicycle Therapeutics is currently does not generate positive expected returns and assumes 3.224% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Bicycle, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bicycle Therapeutics Target Price Odds to finish over Current Price
The tendency of Bicycle Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.73 | 90 days | 5.73 | close to 99 |
Based on a normal probability distribution, the odds of Bicycle Therapeutics to move above the current price in 90 days from now is close to 99 (This Bicycle Therapeutics probability density function shows the probability of Bicycle Stock to fall within a particular range of prices over 90 days) .
Bicycle Therapeutics Price Density |
| Price |
Predictive Modules for Bicycle Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bicycle Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bicycle Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bicycle Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bicycle Therapeutics is not an exception. The market had few large corrections towards the Bicycle Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bicycle Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bicycle Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 0.74 | |
σ | Overall volatility | 0.48 | |
Ir | Information ratio | -0.11 |
Bicycle Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bicycle Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bicycle Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bicycle Therapeutics generated a negative expected return over the last 90 days | |
| Bicycle Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 35.27 M. Net Loss for the year was (169.03 M) with loss before overhead, payroll, taxes, and interest of (210.9 M). | |
| Bicycle Therapeutics currently holds about 372.77 M in cash with (164.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Bicycle Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline |
Bicycle Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bicycle Stock often depends not only on the future outlook of the current and potential Bicycle Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bicycle Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 58.2 M | |
| Cash And Short Term Investments | 879.5 M |
Bicycle Therapeutics Fundamentals Growth
Bicycle Stock prices reflect investors' perceptions of the future prospects and financial health of Bicycle Therapeutics, and Bicycle Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bicycle Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (5.59) % | ||||
| Current Valuation | (192.38 M) | ||||
| Shares Outstanding | 49.93 M | ||||
| Price To Earning | (3.31) X | ||||
| Price To Book | 0.73 X | ||||
| Price To Sales | 14.69 X | ||||
| Revenue | 35.27 M | ||||
| Gross Profit | (210.9 M) | ||||
| EBITDA | (164.89 M) | ||||
| Net Income | (169.03 M) | ||||
| Cash And Equivalents | 372.77 M | ||||
| Cash Per Share | 12.56 X | ||||
| Total Debt | 9.49 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.88 X | ||||
| Book Value Per Share | 8.92 X | ||||
| Cash Flow From Operations | (164.72 M) | ||||
| Earnings Per Share | (3.62) X | ||||
| Market Capitalization | 416.21 M | ||||
| Total Asset | 956.87 M | ||||
| Retained Earnings | (680.79 M) | ||||
| Working Capital | 861.38 M | ||||
| Current Asset | 103.53 M | ||||
| Current Liabilities | 8.46 M | ||||
About Bicycle Therapeutics Performance
By analyzing Bicycle Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Bicycle Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bicycle Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bicycle Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Capital Employed | (0.21) | (0.22) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.19) | (0.20) |
Things to note about Bicycle Therapeutics performance evaluation
Checking the ongoing alerts about Bicycle Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bicycle Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bicycle Therapeutics generated a negative expected return over the last 90 days | |
| Bicycle Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 35.27 M. Net Loss for the year was (169.03 M) with loss before overhead, payroll, taxes, and interest of (210.9 M). | |
| Bicycle Therapeutics currently holds about 372.77 M in cash with (164.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Bicycle Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline |
- Analyzing Bicycle Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bicycle Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Bicycle Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bicycle Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bicycle Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bicycle Therapeutics' stock. These opinions can provide insight into Bicycle Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |